New Oxadiazole/ Benzimidazole Hybrids: Design, Synthesis, and Molecular Docking Studies.

Design, synthesis, molecular docking and biological evaluation of novel 1,5-diarylpyrazole-N,O-dimethyl hydroxamate derivatives as antiproliferative agents.

Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel 1,5-Diarylpyrazole Carboxamide Derivatives as Antiproliferative Agents

Design, Synthesis, Biological and Docking Studies of Novel 6-fluorobenzothiazole Substituted 1,2,4-Triazole Analogues as Prospective Anti-inflammatory Agents.

Novel Benzimidazole/Hydrazone Derivatives as Promising Anticancer Lead Compounds: Design, Synthesis, and Molecular Docking Study

Design, Synthesis, Molecular Docking Studies and in Silico Prediction of ADME Properties of New 5-Nitrobenzimidazole/thiopyrimidine Hybrids as Anti-angiogenic Agents Targeting He

Design, Synthesis and Antifungal Activity of 1,2,4-Triazole/ or 1,3,4- Oxadiazole-ciprofloxacin hybrids

Design, Synthesis, Molecular Docking of Some New Polyhydrobenzothieno￾thiazolopyrimidinedione Glycoside Derivatives with Double Anti-microbial-Anti￾inflammatory Action

Design, molecular docking, synthesis, and in vitro pharmacological evaluation of biomolecules-histone deacetylase inhibitors conjugates with carbohydrazide as a novel zinc-binding

Synthesis, Computational & Docking Studies Of Bis-(4- Hydroxycoumarin-3-Yl) Methanes As Potential Inhibitor For Carbonic Anhydrase, Glyceraldehyde-3-Phosphate Dehydrogenase